A predictive model for MGMT promoter methylation status in glioblastoma based on terahertz spectral data
- 30 March 2025
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 702, 115850
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (GZC20231749)
This publication has 32 references indexed in Scilit:
- Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resectionAnnals of Clinical and Translational Neurology, 2024
- Ensemble learning prediction framework for EGFR amplification status of glioma based on terahertz spectral featuresSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024
- Prediction of IDH mutation status of glioma based on terahertz spectral dataSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023
- Advances in terahertz technology for cancer detection applicationsOptical and Quantum Electronics, 2022
- Biomedical applications of terahertz spectra in clinical and molecular pathology of human gliomaSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2022
- Biomedical Applications of Terahertz Spectroscopy and ImagingTrends in Biotechnology, 2016
- AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alphaJournal of Neuro-Oncology, 2010
- L1Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010
- Disease recognition by infrared and Raman spectroscopyJournal of Biophotonics, 2009
- Angiogenesis in malignant gliomasGlia, 1995